Pharmacology · patient case question

For which condition is donepezil prescribed, and by what mechanism does it act?

Patient case: Alzheimer Disease and Consent for Care

Patient: 72-year-old male

Chief Complaint: Daughter: “He won’t let anyone near his mouth and I think his teeth are getting worse.”

Background: Moderate Alzheimer disease diagnosed 4 years ago. Trigeminal neuralgia on the right, managed medically. Disoriented to time and place; cannot reliably recall the purpose of today’s visit. His daughter holds a durable power of attorney for health care.

Medications: Donepezil 10 mg daily · Carbamazepine 200 mg twice daily

Vital Signs: BP 144/82 mmHg · HR 72 bpm · RR 16 · T 98.2°F

Findings: Generalized plaque accumulation, multiple root caries, and moderate periodontitis. Multiple restorations required. He is calm but does not follow multi-step instructions.

  1. Alzheimer disease — it inhibits acetylcholinesterase
  2. Major depressive disorder — it inhibits serotonin reuptake
  3. Parkinson disease — it is a dopamine precursor
  4. Epilepsy — it enhances GABAergic inhibition
Show answer and explanation

Correct answer: A. Alzheimer disease — it inhibits acetylcholinesterase

  • A. Correct. Donepezil is a centrally acting, reversible acetylcholinesterase inhibitor. By slowing the breakdown of acetylcholine it partially compensates for the cholinergic deficit of Alzheimer disease, producing modest symptomatic benefit without altering the underlying course.
  • B. Incorrect. Serotonin reuptake inhibition describes the SSRI class, such as sertraline and fluoxetine.
  • C. Incorrect. Levodopa combined with carbidopa is the dopamine precursor therapy for Parkinson disease. Donepezil has no dopaminergic action.
  • D. Incorrect. Enhancement of GABAergic inhibition describes benzodiazepines, barbiturates, and several antiepileptics. Donepezil is not an anticonvulsant.

Note: Class members worth knowing: donepezil, rivastigmine, and galantamine are the cholinesterase inhibitors. Memantine works differently, as an NMDA receptor antagonist, and is used in moderate to severe disease.

Practice Pharmacology questions Pharmacology study notes

More Pharmacology practice questions